Core Insights - The automotive consumption market in Jinan High-tech Zone showed strong performance in Q1 2025, with retail sales exceeding 1.4 billion yuan, a year-on-year increase of 5.3%, outperforming the overall retail sales growth in the region [1] Group 1: New Energy Vehicles - New energy vehicles (NEVs) have become the main driver of automotive consumption in Jinan High-tech Zone, with brands like BYD and Lynk & Co expanding their presence [3][4] - BYD's sales in Q1 reached over 1,000 units, marking a 35% increase, with 60%-70% of customers opting for vehicle replacement due to favorable policies [3] - The market share of NEVs is increasing annually, driven by advancements in battery technology and charging infrastructure, making them the preferred choice for younger consumers [4] Group 2: Traditional Automakers' Transformation - Traditional automaker FAW Toyota is adapting to the NEV market by promoting hybrid models, with 70% of its Q1 sales being hybrid vehicles [6] - FAW Toyota's new BZ5 electric SUV, set to launch in June, features a range of 550 kilometers and aims to compete with domestic brands [6] - The company has introduced a "Time for Renewal" plan, offering additional subsidies for older models, effectively stimulating replacement demand [7] Group 3: Policy and Market Dynamics - The Jinan High-tech Zone government has implemented a 2 million yuan subsidy program to boost automotive consumption, which has significantly impacted sales [8] - The subsidy program, combined with national and provincial incentives, has led to a sales increase of 280 million yuan in the region [8] - The automotive market is expected to continue its strong performance in Q2, with companies preparing for increased sales during the May Day holiday [10][11]

证券代码：600807 证券简称：济高发展 公告编号：临2025-032 济南高新发展股份有限公司 公司于 2025 年 4 月 29 日召开第十一届董事会第二十二次会议，审议通过《关于审议公 司续聘 2025 年度会计师事务所的议案》，同意公司继续聘任中兴华为公司 2025 年度财务报 告与内部控制审计机构，该事项尚需提交公司股东大会审议。具体情况如下： 一、拟聘任会计师事务所的基本情况 （一）机构信息 1、基本信息 中兴华，成立于1993年，2000年由国家工商管理总局核准，改制为"中兴华会计师事务 所有限责任公司"，2009年吸收合并江苏富华会计师事务所，更名为"中兴华富华会计师事 务所有限责任公司"，2013年公司进行合伙制转制，转制后的事务所名称为"中兴华会计师 事务所（特殊普通合伙）"。注册地址：北京市丰台区丽泽路20号院1号楼南楼20层；统一 社会信用代码：91110102082881146K。首席合伙人李尊农。2024年收入总额（未经审计） 203,338.19万元，审计业务收入（未经审计）152,989.42万元，证券业务收入（未经审计） 32,048.30万元。2024年度中兴华共承担17 ...

证券代码：600807 证券简称：济高发展 公告编号：临2025-025 济南高新发展股份有限公司 第十一届监事会第十一次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 公司第十一届监事会第十一次会议于2025年4月29日上午11点，在中国（山东）自由贸 易试验区济南片区经十东路7000号汉峪金融商务中心A4-4号楼11层会议室，以现场方式召开， 会议通知和材料于2025年4月19日以电子通讯方式发出。应出席会议监事5名，实际出席会议 监事5名。公司董事会秘书、财务总监列席了会议，符合《中华人民共和国公司法》等有关 法律、行政法规、部门规章、规范性文件和《公司章程》的规定。会议召集人、主持人为公 司监事会主席刘洋先生。 监事会认为：鉴于公司 2024 年末母公司未分配利润余额为负，不具备实施利润分配的 条件，董事会提出的 2024 年度利润分配和资本公积金转增股本方案符合相关利润分配政策， 符合公司经营发展的实际情况，具备合法性、合规性及合理性；董事会决策程序符合有关法 律、法规和《公司章程》的规定，不存在损害公 ...

证券代码：600807 证券简称：济高发展 公告编号：临2025-024 济南高新发展股份有限公司 第十一届董事会第二十二次会议决议公告 该议案已经公司第十一届董事会审计委员会第十二次会议审议通过。 表决结果：8 票同意、0 票反对、0 票弃权。 三、审议通过《关于审议 2024 年年度利润分配及公积金转增股本的议案》； 鉴于 2024 年末母公司未分配利润余额为负，不具备实施利润分配的条件，本年度公司 拟不进行利润分配，亦不进行资本公积金转增股本。 董事会认为因母公司期末未分配利润为负数，不具备实施利润分配的条件，公司 2024 年度不进行利润分配和资本公积金转增股本，该方案符合相关利润分配政策和公司已披露的 股东回报规划，同意该方案并提交公司股东大会审议。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 公司第十一届董事会第二十二次会议于2025年4月29日上午10点，在中国（山东）自由 贸易试验区济南片区经十东路7000号汉峪金融商务中心A4-4号楼11层会议室，以现场和通讯 结合方式召开，会议通知和材料于2025年4月 ...

证券代码：600807 证券简称：济高发展 公告编号：临2025-026 济南高新发展股份有限公司 截至 2024 年 12 月 31 日，母公司报表中期末未分配利润为负值，因此不触及《上海证 券交易所股票上市规则》第 9.8.1 条第一款第（八）项规定的可能被实施其他风险警示的情 形。 三、公司 2024 年度拟不进行利润分配的合理性说明 关于公司2024年度拟不进行利润分配的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 鉴于母公司 2024 年末未分配利润余额为负，不具备实施利润分配的条件，本年度公 司拟不进行利润分配，亦不进行资本公积金转增股本。 ● 该事项已经公司第十一届董事会第二十二次会议、第十一届监事会第十一次会议审 议通过，尚需提交公司 2024 年年度股东大会审议。 ● 公司不存在触及《上海证券交易所股票上市规则》第 9.8.1 条第一款第（八）项规 定的可能被实施其他风险警示的情形。 一、公司 2024 年度利润分配方案的内容 经中兴华会计师事务所（特殊普通合伙）审计，公司 202 ...

济南高新发展股份有限公司 关于营业收入扣除事项的 专项核查意见 中兴华会计师事务所(特殊普通合伙) ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地址：北京市丰台区丽泽路 20 号丽泽 SOHO Ｂ座 20 层 邮编：100073 电话：(010) 51423818 传真：(010) 51423816 中 兴 华 会 计 师 事 务 所 （ 特 殊 普 通 合 伙 ） Z H O N G X I N G H U A C E R T I F I E D P U B L I C A C C O U N T A N T S L L P 地址（ l o c a t i o n ）： 北 京 市 丰 台 区 丽 泽 路 2 0 号 丽 泽 S O H O B 座 2 0 层 2 0 / F, To w e r B , L i z e S O H O , 2 0 L i z e R o a d , F e n g t a i D i s t r i c t , B e i j i n g P R C h i n a 电话（ t e l ）： 0 1 0 - 5 1 4 2 3 ...

关于济南高新发展股份有限公司 标的资产2024年度业绩承诺 实现情况的专项审核报告 中兴华会计师事务所(特殊普通合伙) ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地址：北京市丰台区丽泽路 20 号丽泽 SOHO Ｂ座 20 层 邮编：100073 电话：(010) 51423818 传真：(010) 51423816 中 兴 华 会 计 师 事 务 所 （ 特 殊 普 通 合 伙 ） Z H O N G X I N G H U A C E R T I F I E D P U B L I C A C C O U N T A N T S L L P 地址（ l o c a t i o n ）： 北 京 市 丰 台 区 丽 泽 路 2 0 号 丽 泽 S O H O Ｂ 座 2 0 层 2 0 / F, To w e r B , L i z e S O H O , 2 0 L i z e R o a d , F e n g t a i D i s t r i c t , B e i j i n g P R C h i n a 电 话 （ t e l ）： 0 1 0 ...

济南高新发展股份有限公司 内部控制审计报告书 中兴华会计师事务所(特殊普通合伙) ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地址：北京市丰台区丽泽路 20 号丽泽 SOHO Ｂ座 20 层 邮编：100073 电话：(010) 51423818 传真：(010) 51423816 中 兴 华 会 计 师 事 务 所 （ 特 殊 普 通 合 伙 ） Z H O N G X I N G H U A C E R T I F I E D P U B L I C A C C O U N T A N T S L L P 地址（ l o c a t i o n ）： 北 京 市 丰 台 区 丽 泽 路 2 0 号 丽 泽 S O H O Ｂ 座 2 0 层 2 0 / F, To w e r B , L i z e S O H O , 2 0 L i z e R o a d , F e n g t a i D i s t r i c t , B e i j i n g P R C h i n a 电 话 （ t e l ）： 0 1 0 - 5 1 4 2 3 8 1 8 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥87,692,970.19, representing a 57.81% increase compared to ¥55,568,814.91 in the same period last year[4] - The net profit attributable to shareholders was -¥26,403,899.90, a decrease from -¥17,721,944.34 year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥11,573,467.62, an improvement from -¥18,124,727.53 in the previous year[4] - The basic earnings per share were -¥0.03, compared to -¥0.02 in the previous year[5] - The weighted average return on equity decreased to -46.87%, down 38.19 percentage points from -8.68% year-on-year[5] - The company reported a significant amount of other receivables at ¥727,354,583.72, which increased from ¥715,543,599.20[16] - Net loss for Q1 2025 was ¥27,995,472.21, compared to a net loss of ¥23,097,131.42 in Q1 2024, indicating a worsening of 21.1%[24] - The comprehensive loss for Q1 2025 was ¥29,357,025.76, compared to a loss of ¥24,283,463.71 in Q1 2024, indicating a decline of 21.4%[24] Cash Flow - The net cash flow from operating activities was -¥3,008,918.45, a significant improvement from -¥66,137,041.89 in the same period last year[4] - Cash flow from operating activities showed a net outflow of ¥3,008,918.45 in Q1 2025, an improvement from a net outflow of ¥66,137,041.89 in Q1 2024[27] - The company’s cash inflow from operating activities totaled ¥164,740,037.09, down from ¥261,579,966.04 in Q1 2024[27] - The net cash flow from investing activities was -$3,219,849.35, a significant decrease from $25,896,319.87 in the previous period[28] - Total cash inflow from financing activities amounted to $4,864,722.00, while cash outflow was $18,804,573.50, resulting in a net cash flow of -$18,804,573.50[28] - The net increase in cash and cash equivalents was -$25,017,121.68, compared to -$74,237,430.38 in the prior period[28] - The ending balance of cash and cash equivalents was $87,296,105.17, down from $111,750,209.20 at the beginning of the period[28] - Cash paid for debt repayment was $10,327,011.17, a decrease from $32,653,449.97 in the previous period[28] - Cash dividends and interest payments totaled $2,115,654.27, down from $5,651,596.53[28] - The impact of exchange rate changes on cash and cash equivalents was a positive $16,219.62, contrasting with a negative impact of -$234,992.61 in the previous period[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,518,661,280.09, a decrease of 2.91% from ¥2,594,051,414.27 at the end of the previous year[5] - Total current assets as of March 31, 2025, amount to ¥1,956,478,693.40, a decrease from ¥2,032,597,246.22 as of December 31, 2024[16] - Total liabilities as of March 31, 2025, are ¥1,399,360,544.87, down from ¥1,497,532,368.75[17] - The company has a total asset value of ¥2,518,661,280.09, down from ¥2,594,051,414.27[17] - The total equity attributable to shareholders decreased to ¥67,984,169.51 from ¥78,726,139.80, reflecting a decline of 13.5%[18] Shareholder Information - Total number of common shareholders at the end of the reporting period is 51,918[11] - The largest shareholder, Jinan High-tech Urban Construction Development Co., Ltd., holds 142,307,521 shares, accounting for 16.09% of total shares[11] Operating Costs and Revenue - Total operating costs for Q1 2025 were ¥108,630,148.49, up 36.5% from ¥79,591,118.15 in Q1 2024[23] - The increase in operating revenue was mainly attributed to the growth in steel trading business income[8] - Research and development expenses for Q1 2025 were ¥2,430,005.86, compared to ¥2,136,878.64 in Q1 2024, marking an increase of 13.8%[23] - The company incurred financial expenses of ¥5,814,925.10 in Q1 2025, down from ¥7,001,537.62 in Q1 2024, a reduction of 17.0%[23] Other Information - The company has no significant new product launches or technological developments mentioned in the reports[12] - The company will not apply new accounting standards starting from 2025[28] - The financial report is overseen by key personnel including Wang Chengdong, Lei Xuefeng, and Wang Dandan[28]

Financial Performance - The net profit attributable to shareholders for 2024 was -805,806,371.13 CNY, a significant decline compared to -95,101,251.47 CNY in 2023[6] - Operating revenue for 2024 decreased by 48.02% to 372,176,682.13 CNY from 715,952,553.53 CNY in 2023[22] - The company reported a decrease of 37.39% in revenue after excluding non-core business income, totaling 365,670,907.00 CNY in 2024[22] - In 2024, the company reported a revenue of 372.18 million RMB, a decrease of 48.02% year-over-year[31] - The company's net profit attributable to shareholders was -805.81 million RMB, reflecting significant losses compared to previous periods[31] - Non-recurring gains and losses for 2024 totaled -618.20 million RMB, indicating significant financial challenges[27] - The company reported a significant decline in net profit for its subsidiary, Ji Chang Fa, with a net loss of CNY 10,729.14 million, a decrease of 366.25% year-on-year due to reduced revenue in the in vitro diagnostic business[91] - The average net profit over the last three accounting years was -294,184,814.88 RMB, with no cash dividends distributed during this period[142] Cash Flow and Assets - The cash flow from operating activities for 2024 was 14,078,140.33 CNY, a recovery from -332,986,217.14 CNY in 2023[22] - The cash flow from operating activities showed improvement with a net cash inflow of 80.31 million RMB in the fourth quarter[24] - As of December 31, 2024, the company's total assets amounted to CNY 2,594.05 million, with net assets attributable to shareholders of CNY 78.73 million[51] - Total assets increased by 15.99% to 2,594,051,414.27 CNY at the end of 2024, compared to 2,236,447,898.71 CNY at the end of 2023[22] - The company's total assets included cash and cash equivalents of 143,538,348.10 RMB, which represented 5.53% of total assets, down 31.43% from the previous period[70] Business Operations and Strategy - The company is focusing on its core life sciences business and exploring new business development models to strengthen its main operations[32] - The company is actively seeking investment and acquisition opportunities in the life sciences sector to enhance its strategic industry layout[33] - The company has initiated a partnership with a related party to provide operational management services for a biopharmaceutical industrial park, aiming to expand its main business cooperation[33] - The company has focused on its core life and health business, divesting from the landscaping and municipal construction business in 2023[53] - The company aims to expand its life and health business by utilizing national policy advantages and the biomedical industry in Jinan High-tech Zone[49] Research and Development - The company has developed over 200 in vitro diagnostic reagents, including more than 150 molecular diagnostic reagents, covering 80% of nationally mandated infectious diseases[42] - The company is committed to enhancing its R&D capabilities to maintain product competitiveness amid rapid technological advancements in the IVD industry[102] - The company plans to enhance R&D investment, with an increase of RMB 5 million in R&D expenses for 2024[162] - The company has engaged in debt restructuring financing activities totaling 80,000,000.00 RMB, with ongoing processes to release previously restricted assets[79] Market and Industry Trends - The global in vitro diagnostics market is projected to reach $109.2 billion by 2024, with a CAGR of approximately 4.3% expected until 2029[39] - China's in vitro diagnostics market is estimated to be around $6.1 billion in 2024, with a projected CAGR of 8.0% until 2029[40] - The IVD industry is experiencing a structural transformation, with a focus on smart healthcare solutions, as highlighted by major companies aiming for digital integration in their operations[93] - The trend of domestic substitution in the IVD market is becoming increasingly evident, with over 70% of biochemical reagents now produced domestically, driven by government policies encouraging local innovation[94] Governance and Compliance - The company has not faced any regulatory actions or governance issues during the reporting period, ensuring compliance with relevant laws and regulations[104] - The company maintains independence from its controlling shareholder, ensuring fair and reasonable transactions without harming the interests of minority shareholders[105] - The board of directors consists of 9 members, including 3 independent directors, and held 7 meetings during the reporting period[106] - The company has established a management system for insider information and has not reported any violations of insider trading during the reporting period[107] Legal and Litigation Matters - The company has faced significant litigation, including a contract dispute with Yang Haoyu, resulting in a settlement where the company agreed to pay CNY 47,542,545.65 for debt acquisition, with CNY 10 million already paid[169] - The company is currently appealing a court decision regarding a loan contract worth CNY 150 million, where the court ruled the contract invalid[169] - The company has been involved in multiple lawsuits related to securities false statements, with most investor claims resolved[169] Shareholder Information - The total number of ordinary shareholders as of the end of the reporting period is 51,974, an increase from 51,918 in the previous month[192] - The largest shareholder, Jinan High-tech City Construction Development Co., Ltd., holds 142,307,521 shares, accounting for 16.09% of the total shares[194] - The company has not reported any changes in its share capital structure during the reporting period[191] Environmental and Social Responsibility - The company has not established an environmental protection mechanism and did not invest in environmental protection funds during the reporting period[152] - The company has actively implemented government requirements for environmental protection and pollution prevention, adhering to relevant laws and regulations[155] - The company has not reported any major arbitration matters during the year[169]